IL1A and NDN

  • Number of citations of the paper that reports this interaction (PMID 12913118)
  • 15
  • Data Source:
  • HPRD (in vitro, two hybrid)

IL1A

NDN

Gene Name interleukin 1, alpha necdin, melanoma antigen (MAGE) family member
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 9 interactors: CAPN1 CASP1 HAX1 IL1R1 IL1R2 IL1RAP NDN NFKBIE S100A13 43 interactors: APBB1IP ARSE BLOC1S6 CALCOCO2 CCDC136 CDR2 DTNBP1 E2F1 E2F4 EGFR EID1 EPAS1 FAM131C FSD2 FXR2 GKAP1 GOLGA2 HIF1A HNRNPU IFFO1 IL1A IL32 LAX1 LPXN MIER2 MKRN2 MPP6 N6AMT2 NEFL NGFR NUBP1 NUCB1 NUCB2 P4HA3 PJA1 PPFIA1 SERTAD3 SSX2IP TFIP11 TP53 U2AF1 ZBTB1 ZBTB7B
Entrez ID 3552 4692
HPRD ID 00988 03667
Ensembl ID ENSG00000182636
Uniprot IDs P01583 Q99608
PDB IDs 1ITA 2ILA 2KKI 2L5X
Enriched GO Terms of Interacting Partners?
Tagcloud ?
45mg  amenable  copy  curative  cytokine  dacomitinib  eligible  endpoint  evaluable  exploratory  forty  goals  harboring  her4  il1b  il4  il6  il8  irreversible  manageable  p16ink4a  pfs  pi3k  pik3ca  platinum  progressed  recistv1  scchn  shorter 
biallelically  cancerous  cdkn1c  coordinately  deregulated  deregulating  deregulation  dmr  dmrs  exclusive  h19  hoxc6  hyper  hypo  igf2  ign  imprinted  imprinting  lit1  meg3  plagl1  ppp1r9a  presumptive  prostatic  pyrosequencing  qrt  silico  wondered  zac1 
Tagcloud (Difference) ?
45mg  amenable  copy  curative  cytokine  dacomitinib  eligible  endpoint  evaluable  exploratory  forty  goals  harboring  her4  il1b  il4  il6  il8  irreversible  manageable  p16ink4a  pfs  pi3k  pik3ca  platinum  progressed  recistv1  scchn  shorter 
biallelically  cancerous  cdkn1c  coordinately  deregulated  deregulating  deregulation  dmr  dmrs  exclusive  h19  hoxc6  hyper  hypo  igf2  ign  imprinted  imprinting  lit1  meg3  plagl1  ppp1r9a  presumptive  prostatic  pyrosequencing  qrt  silico  wondered  zac1 
Tagcloud (Intersection) ?